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PVALVULAR HEART DISEASE
Failure of Guideline Adherence for Intervention
in Patients With Severe Mitral Regurgitation
David S. Bach, MD, Mazen Awais, MD, Hitinder S. Gurm, MD, Sarah Kohnstamm, MD
Ann Arbor, Michigan
Objectives This study sought to evaluate the incidence with which adult patients with significant mitral regurgitation (MR)
do not undergo surgical intervention despite guideline recommendations, and the associated considerations re-
sulting in no intervention.
Background Despite the existence of accepted guidelines, many patients with severe symptomatic heart valve disease might
not undergo intervention.
Methods At a single large tertiary medical center, patients were retrospectively identified who had moderate-to-severe or
severe MR on echocardiographic imaging during 2005. Clinical data were reviewed to determine indications for
intervention and whether surgery was performed.
Results During 2005, 300 patients were identified with significant MR, including 188 with functional MR and 112 with
organic MR. Mitral surgery was performed in 30 of 188 patients with functional MR, mostly to treat heart failure
or during another cardiac surgical procedure. Mitral surgery was performed in 59 (53%) of 112 patients with
organic MR. Among unoperated patients with organic MR, common reasons included stable left ventricular size
or function, absence of symptoms, and prohibitive comorbidities. Using American College of Cardiology/Ameri-
can Heart Association guidelines, 1 or more indication for intervention was present in 39 (74%) of 53 unoper-
ated patients. Perioperative mortality risk was not higher for patients who did not undergo surgery (median
1.2%, interquartile range [IQR] 0.4% to 3.3%) than for those who did (median 1.1%, IQR 0.6% to 5.3%; p 
0.71). During follow-up, there were 12 cardiac and 2 unexplained deaths.
Conclusions Among patients with severe organic MR, surgical intervention occurred in approximately one-half. However, ac-
cepted guideline indications for intervention were present in the majority of unoperated patients. Objectively as-
sessed operative risk was not prohibitive in many unoperated patients. (J Am Coll Cardiol 2009;54:860–5)
© 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.03.079t
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thronic, severe organic mitral regurgitation (MR) results in
eft ventricular (LV) dilation and systolic dysfunction, with
ventual heart failure (1) and death (2). With no acceptable
edical therapy, American College of Cardiology (ACC)/
merican Heart Association (AHA) (3,4) and European
ociety of Cardiology guidelines (5) recommend surgical
ntervention in patients with chronic, severe organic MR
nd heart failure, LV systolic dysfunction or significant LV
nlargement, or new atrial fibrillation or pulmonary hyper-
ension. In the setting of ischemic (6) or nonischemic LV
ysfunction (7), functional MR also is associated with excess
ortality. However, there remains broad variation in indi-
ations to intervene on patients with functional MR (1,3–5).
rom the Department of Internal Medicine, Division of Cardiovascular Medicine,
niversity of Michigan, Ann Arbor, Michigan. Funding for this research was
rovided in part by Edwards Lifesciences. Dr. Bach has received research funding
rom Edwards Lifesciences and Medtronic, and consulting fees from Edwards
ifesciences, Medtronic, St. Jude Medical, and CVRx.M
Manuscript received January 6, 2009; revised manuscript received March 16, 2009,
ccepted March 16, 2009.Despite unequivocal recommendations for intervention in
he setting of severe organic MR with symptoms, LV dilation,
r LV systolic dysfunction, prevalence studies suggest that it is
ot uncommon that patients do not undergo surgery (8,9). In
ddition, a survey of cardiologists treating adults in Canada
howed that only 57.2% recognized an ejection fraction (EF) of
0% to 60% and only 15.6% recognized functional class II
ymptoms as indications for intervention (10). No studies to
ate directly address the level of undertreatment of patients
ith MR. The purpose of this study was to evaluate the
ncidence with which adult patients with significant MR do
ot undergo surgical intervention, and the associated consid-
rations resulting in no intervention.
ethods
tudy population. The University of Michigan Echocar-
iography Laboratory database was retrospectively reviewed
o identify adult patients with moderate-to-severe or severe
R documented on any echocardiogram during 2005.
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August 25, 2009:860–5 Unoperated Mitral Regurgitationatients with organic MR and patients with functional MR
ere considered separately.
R. MR severity was determined at the time of clinical
chocardiographic analysis based on overall clinical assessment
sing all available echocardiographic and Doppler criteria,
ncluding color-flow Doppler jet size, jet eccentricity, charac-
eristics of the proximal flow convergence zone, and jet
uration; a semiquantitative system of none, trivial, mild,
ild-to-moderate, moderate, moderate-to-severe, and se-
ere was used (11). For purposes of determining interven-
ion and outcomes, significant (severe) MR was defined as
oderate-to-severe or severe.
MR was defined as organic in the setting of an identifi-
ble anatomic mitral valve abnormality. Patients with active
nfective endocarditis were excluded from analysis. MR was
efined as functional in the setting of LV enlargement
nd/or regional or global LV dysfunction responsible for
alcoaptation of functionally normal mitral leaflets. Isch-
mic MR was defined as functional MR in patients with
schemic LV systolic dysfunction.
linical data. University of Michigan electronic medical
ecords were reviewed for pertinent medical information
ncluding age, sex, and cardiac and noncardiac diseases and
omorbidities. Records were further reviewed for symptoms
eferable to chronic MR, including exertional or nocturnal
yspnea, orthopnea, peripheral edema, or progressive de-
line in functional status without other explanation. End
oints were referral to cardiology, referral to cardiothoracic
urgery, and performance of mitral valve surgery. For
atients who did not undergo surgery, reasons were deter-
ined by review of all available records. Estimated periop-
rative (30-day) risks of mortality and morbidity for oper-
ted and unoperated patients were calculated using the
ociety of Thoracic Surgery Adult Cardiac Surgery Risk
alculator (12), using historical and clinical data at the time
f the echocardiogram documenting severe MR. The study
rotocol was reviewed and approved by the institutional
eview board of the University of Michigan.
tatistical analysis. Data with normal distribution (age,
chocardiography/Doppler variables) are presented as mean
SD or as number and percent; comparisons between groups
ere made using Student t tests (2-sided). Data with non-
ormal distribution (perioperative risk) are presented as me-
ian and interquartile range (IQR); comparisons between
roups were made usingMann-WhitneyU tests. Comparisons
f categorical variables between groups were made using
hi-square tests or Fisher exact tests (when the frequency of
ny event was5). Survival was determined using the Kaplan-
eier method. Differences were considered significant at a p
alue 0.05. Statistical analysis was performed using SPSS
ersion 11.5 (SPSS, Inc., Chicago, Illinois).
esults
atients. During calendar year 2005, 303 patients had
chocardiographic evidence of moderate-to-severe or severe
i
pR. Of these, 3 (1%) were ex-
luded from analysis because no
edical information was avail-
ble other than the echocardio-
ram. The remaining 300 pa-
ients included 172 men (57%)
nd 128 women (43%), mean age
0.1 16.5 years (range 18 to 91
ears). There were 112 (37%)
atients with organic MR and
88 (63%) with functional MR
elated to an underlying cardio-
yopathy (95 [32% of total]
onischemic and 93 [31% of total] ischemic).
unctional MR. Demographic and echocardiographic
ata for patients with nonischemic and ischemic functional
R are summarized in Tables 1 and 2, respectively.
atients who underwent surgery did not differ substantially
rom unoperated patients other than a slightly higher
VEF. No patient underwent heart transplant or LV assist
evice placement. Predicted risk of perioperative mortality
as not different for patients who underwent surgery
median 1.1%, IQR 0.7% to 1.8%, range 0.4% to 8.8%)
ompared with those who did not (median 0.9%, IQR 0.5%
o 2.2%, range 0.3% to 14.1%; p  0.70). More patients
ho underwent intervention were referred to the institution
irectly to a cardiac surgeon (5 of 15 vs. 0 of 80, p 0.001).
f 15 operated patients, 12 (80%) underwent intervention
or intractable symptoms of heart failure and 3 underwent
itral valve surgery for functional MR at the time of
nother cardiac procedure.
Patients with ischemic MR who underwent surgery were
imilar to unoperated patients. Predicted risk of periopera-
ive mortality was not different for patients who underwent
urgery (median 3.2%, IQR 1.7% to 6.4%, range 0.7% to
7.2%) compared with those who did not (median 2.8%,
QR 1.4% to 4.7%, range 0.3% to 23.7%; p  0.57). Mitral
alve surgery was performed at the time of other cardiac
emographic andchocardiographic Data for Patientsith Function l Nonischemic Mitral Regurgitation
Table 1
Demographic and
Echocardiographic Data for Patients
With Functional Nonischemic Mitral Regurgitation
All Patients Operated Unoperated p Value
n 95 15 (16%) 80 (84%)
Age (yrs) 53.0 15.9 56.1 14.2 52.4 16.2 0.42
Range 18–89 33–79 18–89
Male sex 51 (60%) 10 (67%) 41 (51%) 0.27
Echocardiography
LA diameter (mm) 50.9 8.2 53.6 8.4 50.6 8.1 0.26
LVIDD (mm) 66.3 12.5 69.3 12.5 65.7 12.5 0.34
LVIDS (mm) 56.5 15.7 58.5 13.8 56.1 16.0 0.62
LVEF (%) 25.6 16.5 33.5 15.1 24.1 16.1 0.05
RVSP (mm Hg) 49.3 15.1 52.6 20.9 48.9 14.4 0.50
A left atrium; LVEF left ventricular ejection fraction; LVIDD left ventricular internal diameter
Abbreviations
and Acronyms
ACC  American College of
Cardiology
AHA  American Heart
Association
EF  ejection fraction
IQR  interquartile range
LV  left ventricle/
ventricular
MR  mitral regurgitationn diastole; LVIDS  left ventricular internal diameter in sy
ressure.stole; RVSP  right ventricular systolic
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Unoperated Mitral Regurgitation August 25, 2009:860–5urgery in 8 patients. The remaining 7 patients underwent
itral valve surgery for treatment of heart failure.
rganic MR. Etiologies of organic MR included myxo-
atous degeneration in 55 patients (49%), rheumatic dis-
ase in 18 patients (16%), healed endocarditis in 16 patients
14%), degenerative calcific disease or other nonspecific
eaflet thickening in 6 patients (5%), congenital disease in 5
atients (4%), hypertrophic cardiomyopathy in 1 patient
1%), radiation valvulopathy in 1 patient (1%), structural
rosthetic valve dysfunction in 2 patients (2%), and degen-
ration of mitral repair in 8 patients (7%). Demographic and
chocardiographic data are summarized in Table 3. In
eneral, operated and unoperated patients were similar. The
istribution of indications for mitral valve surgery based on
he 1998 ACC/AHA guidelines (3) is shown in Table 4.
he 2 patients who underwent surgery without an identified
ndication underwent mitral valve repair for myxomatous
egeneration.
Of 53 unoperated patients, 43 (81%) were followed up by
cardiologist; only 5 (9%) were referred to a cardiothoracic
urgeon for evaluation. Stated reasons not to refer for
ntervention are shown in Table 5. Among 9 patients for
hom absence of symptoms was cited, 6 (67%) had at least
1998 ACC/AHA Class I or IIa indication for interven-
ion. Similarly, an indication for intervention was present in
emographic and Echocardiographic Dataor Patients With Is emic Mitral RegurgitationTable 2 Demographic and Echo ardiographic Datafor Patients With Ischemic Mitral Regurgitation
All Patients Operated Unoperated p Value
n 93 15 (16%) 78 (84%)
Age (yrs) 67.6 12.4 67.2 11.2 67.7 12.7 0.88
Range 44–91 52–83 44–91
Male sex 58 (62%) 9 (60%) 49 (63%) 0.84
Echocardiography
LA diameter (mm) 49.4 7.6 50.5 6.2 49.2 7.8 0.56
LVIDD (mm) 59.1 11.5 57.2 11.6 59.4 11.5 0.54
LVIDS (mm) 46.6 13.8 41.4 18.6 47.5 12.8 0.16
LVEF (%) 32.3 17.2 34.6 20.5 31.8 16.6 0.58
RVSP (mm Hg) 51.2 15.8 61.0 18.8 49.4 14.7 0.02
bbreviations as in Table 1.
emographic and Echocardiographic Dataor Patients With Organic Mitral RegurgitationTable 3 Demog aph and Echo a d ographic Datafor Patients With Organic Mitral Regurgitation
All Patients Operated Unoperated p Value
n 112 59 (53%) 53 (47%)
Age (yrs) 59.8 17.2 57.2 17.4 62.8 16.7 0.09
Range 20–90 20–88 23–90
Male sex 63 (56%) 33 (56%) 30 (57%) 0.94
Echocardiography
LA diameter (mm) 48.4 7.8 48.4 7.1 48.4 8.5 0.97
LVIDD (mm) 52.2 8.0 52.1 8.8 52.4 7.4 0.87
LVIDS (mm) 33.6 8.0 33.2 7.6 33.9 8.4 0.70
LVEF (%) 58.6 11.4 57.6 11.2 59.5 11.5 0.42
RVSP (mm Hg) 46.3 19.0 45.6 17.8 46.8 19.9 0.80
s
bbreviations as in Table 1.of 17 patients (47%) in whom surgery was not recom-
ended because of stable LV size and EF.
During a median interval of 776 days (IQR 193 to 1,002
ays, range 0 to 1,225 days) after echocardiography, 17
atients (32%) with organic MR died (Table 5), including
2 patients who died of a cardiac cause, 3 who died of a
oncardiac cause, and 2 in whom cause of death was not
ocumented. The Kaplan-Meier 6- and 12-month freedom
rom cardiac death was 86% and 79%, respectively.
There were 4 patients in whom the diagnosis of MR was
ever acknowledged after the echocardiogram. All 4 had
ndications for intervention, including pulmonary hyperten-
ion in 1 patient, pulmonary hypertension and atrial fibril-
ation in 1 patient, LV enlargement and systolic dysfunction
n 1 patient, and symptoms, LV enlargement, atrial fibril-
ation, and pulmonary hypertension in 1 patient. In 2
atients, the diagnosis was acknowledged but surgery was
ever addressed. One patient had LV dysfunction, and 1
atient had symptoms and atrial fibrillation.
Risks of perioperative mortality and morbidities are shown
n Table 6; distributions of risk are shown in Figure 1. In all
ategories, risks were not significantly different for operated
nd unoperated patients. The risk of perioperative mortality
revalence of Indications for Surgical Interventionor Chronic Severe M tral Regurgitation in Patientsith Organic Mitral Regurgitation Based on th998 ACC/AHA Guidelines*
Table 4
Prevalence of Indications for Surgical Intervention
for Chronic Severe Mitral Regurgitation in Patients
With Organic Mitral Regurgitation Based on the
1998 ACC/AHA Guidelines*
All Patients Operated Unoperated p Value
n 112 59 53
Symptoms 53 (47%) 29 (49%) 24 (45%) 0.68
LVIDS 45 mm 11 (10%) 5 (8%) 6 (11%) 0.61
LVEF 60% 50 (45%) 26 (44%) 24 (45%) 0.90
Atrial fibrillation 26 (23%) 14 (24%) 12 (23%) 0.89
RVSP 50 mm Hg 25 (22%) 9 (15%) 16 (30%) 0.06
Any indication 96 (86%) 57 (97%) 39 (74%) 0.0001
See Bonow et al. (3) for the 1998 ACC/AHA guidelines.
ACC/AHA American College of Cardiology/American Heart Association; other abbreviations as
n Table 1.
ationale by Which Mitrallve Surgery Was Not Performedn 53 Unop rated Patients With Organic MR
Table 5
Rationale by Whic Mitral
Valve Surgery Was Not Performed
in 53 Unoperated Patients With Organic MR
Rationale n Death
Cardiac
Death
Interval to
Cardiac Death
(days)
Asymptomatic 9 (17%) 1 0 —
Stable LVEF, stable chambers 17 (32%) 3 3 186, 839, 855
MR improved on subsequent
echocardiogram
6 (11%) 1 1 213
Comorbidities/risk 10 (19%) 7* 4 3, 5, 26, 43
Patient refused 4 (%) 2 2 3, 32
Died before planned evaluation 1 (%) 1 1 5
MR unrecognized 4 (%) 1† 0 —
MR ignored 2 (%) 1 1 232
There were 4 cardiac deaths, 2 noncardiac deaths, and 1 death of undocumented cause. †The
ingle death was of undocumented cause.
MR  mitral regurgitation; other abbreviations as in Table 1.
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August 25, 2009:860–5 Unoperated Mitral Regurgitationor 10 patients who did not undergo surgery because of cited
omorbidities and high operative risk (median 3.7%, IQR
.1% to 6.3%, range 2.5% to 49.8%) was higher than for the
ohort who underwent mitral valve surgery (p  0.002).
owever, calculated perioperative mortality in 8 of these 10
atients (2.5%, 2.9%, 3.1%, 3.1%, 3.3%, 4.1%, 6.0%, 6.4%)
as substantially 10%, and the calculated operative risk
or all but 1 (49.8%) was lower than the upper range of
perative risks for patients who underwent surgery.
iscussion
rganic MR and functional MR are inherently different in
heir management as well as their causes (1). Functional
R may respond to treatment of the underlying cardiomy-
pathy, whereas no accepted medical therapy exists for
rganic MR. Although there are discrete indications for
perative intervention in patients with chronic severe or-
anic MR, there are no widely accepted indications for
urgery in patients with functional MR other than as a
oncomitant procedure at the time of other cardiac surgical
ntervention (1,3–5).
unctional MR. By definition, patients with functional
R had underlying disease of the LV; patients were evenly
ivided between nonischemic and ischemic etiologies. The
ajority of patients who underwent surgery for nonischemic
R did so because of intractable symptoms of heart failure.
ost patients who underwent intervention for ischemic
R did so at the time of another cardiac surgical procedure.
ecent (3) and current (4,5) guidelines do not stress surgical
ntervention for functional MR. As such, the observed low
ates of intervention could be anticipated, and are not in
onflict with guideline recommendations (3–5) or standard
f care (1).
rganic MR. Approximately one-half of 112 patients with
evere organic MR underwent surgical intervention. Based
n the 1998 ACC/AHA guidelines on the management of
atients with heart valve disease (3), which were pertinent at
he time when echocardiograms were performed, class I and
Ia indications for intervention are symptoms, LV enlarge-
ent (systolic dimension 45 mm) or systolic dysfunction
EF 60%), new atrial fibrillation, or pulmonary artery
Calculated Percent Operative Risks* for PatientTable 6 Calculated Percent Operative Risks
All Patients
n 112
Mortality (%) 1.2 (0.5–3.4)
Total morbidity or mortality (%) 15.0 (8.1–23.9)
Prolonged length of stay (%) 6.2 (2.6–12.4)
Permanent stroke (%) 1.3 (0.8–2.1)
Prolonged ventilation (%) 7.3 (4.1–14.1)
Infection (%) 0.1 (0.1–0.2)
Renal failure (%) 2.5 (1.1–5.3)
Reoperation (%) 6.9 (5.1–9.7)
*Values are median (interquartile range).ypertension (systolic pressure 50 mm Hg). Almost all oatients who underwent surgery had 1 or more indication
or intervention; only 2 patients underwent prophylactic
itral valve repair for myxomatous degeneration. However,
early three-fourths of patients who did not undergo
urgery also had 1 or more indication for intervention.
noperated patients with organic MR. The rationales for
ot performing surgery could be divided into several common
hemes. The most common related to a belief thatMRwas not
current threat based on stable chamber sizes (17 of 53
atients), absence of symptoms (n  9), or less MR noted on
subsequent echocardiogram (n  6). Although subsequent
R improvement could be a logical reason to defer interven-
ion, most patients met other criteria for intervention. Further,
uidelines do not recommend continued follow-up once an
ndication for intervention is present. Together, these finding
uggest a lack of familiarity with longstanding guideline rec-
mmendations or a lack of respect for them.
This study was not powered to address the survival of
noperated patients. However, mortality was significant
12-month freedom from cardiac death 79%). Only 3 of 17
atients died of noncardiac causes.
Among patients who did not undergo intervention, there
as a broad range of estimated operative mortality risk.
owever, most operated and unoperated patients with
rganic MR had low estimated risks of perioperative mor-
ality and morbidity, with outliers notably present in both
roups. Even among 10 patients in whom surgery was not
erformed because of a perception of excessive operative
isk, the estimated mortality risk in 8 patients was well
elow 10%, and exceeded the upper range of risk of operated
atients in only 1 patient. Although most unoperated
atients were followed by a cardiologist, few were referred
or evaluation by a cardiothoracic surgeon. Many patients
or whom surgical risk was thought to be prohibitive likely
ould have been acceptable surgical candidates.
ow rate of intervention in perspective. It may be sur-
rising that almost one-half of patients with organic MR
nd an indication for intervention did not undergo surgery.
dmittedly, this single-center experience may not be rep-
esentative of broader practice patterns. However, published
tudies suggest that this scenario may be common. Studies
th Organic Mitral RegurgitationPatients With Organic Mitral Regurgitation
Operated Unoperated p Value
59 53
1.1 (0.6–3.5) 1.2 (0.4–3.3) 0.71
14.4 (9.4–23.5) 14.9 (7.8–25.5) 0.93
5.7 (3.1–11.8) 6.7 (2.2–12.7) 0.68
1.2 (0.8–2.0) 1.5 (0.8–2.7) 0.22
7.7 (4.5–13.5) 7.2 (3.8–15.4) 0.73
0.1 (0.1–0.2) 0.1 (0.1–0.2) 0.45
2.5 (1.2–5.0) 2.5 (0.9–5.4) 0.79
6.7 (5.1–9.6) 7.5 (5.1–10.7) 0.70s Wi* forn the prevalence of MR suggest that many patients with
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Unoperated Mitral Regurgitation August 25, 2009:860–5ignificant organic MR do not undergo intervention (8,9).
he Euro Heart Survey (13) suggested that no intervention
as performed in 31.8% of patients despite both severe
ingle-valve disease and severe symptoms. In addition,
tudies of aortic stenosis suggest that between 40% and 60%
f patients with severe symptomatic aortic stenosis do not
ndergo valve replacement (14–17).
The reasons that so many patients do not undergo
ntervention likely are complex. Previous studies on why
Figure 1 Risks of Perioperative Mortality
and Total Morbidity and Morbidity
Risks of (A) perioperative mortality and (B) total morbidity and mortality. Distri-
bution of calculated (STS Adult Cardiac Surgery Risk Calculator) operative risk
among operated and unoperated patients with severe organic mitral regurgita-
tion. The first and third quartile for each dataset are defined by the rectangle;
the data median by the heavy crossbar; bars define the lowest and greatest
values that are not outliers (falling within 1.5 times the interquartile range);
outliers are depicted as open circles and extreme outliers (values outside 3
times the interquartile range) as asterisks. The distribution of risk was skewed
but similar among operated and unoperated patients.hysicians fail to adhere to published guidelines note com-on themes including lack of awareness, lack of familiarity,
ack of agreement with recommendations, and inertia of
revious practice (18). However, the 1998 ACC/AHA
uidelines had been in place for years at the time of this
tudy, arguing against inertia. Rather, the relatively small
ole played by heart valve disease in the overall practice of
ardiovascular medicine may result in lack of familiarity
ith practice guidelines. Other contributing factors may
nclude the subtle nature of symptoms, patient denial, and
ifestyle adjustment to avoid symptoms. Further, there may
e a tendency to overestimate operative risk in some patients
17), and to both overestimate the risk and underestimate
he benefit of surgery for elderly patients (14,16). Practice
mprovement may come from education about current
uidelines as well as a means to objectively estimate peri-
perative risk.
tudy limitations. This was an observational retrospective
urvey of patient management at a single institution; find-
ngs might not be representative of broader practice pat-
erns. Patient characteristics were dependent on the tertiary
eferral nature of the institution. It is not always possible in
etrospect to definitively reconstruct the rationale for med-
cal recommendations; however, with careful review, ratio-
ale typically was apparent. The survey was not designed to
ddress the prevalence of MR or the outcomes of patients
ith the diagnosis of MR with or without intervention.
ignificant MR in this study was taken to include both
evere and moderate-to-severe MR; it is possible that less
han severe MR, as well as the subjective nature of echo-
ardiographic determination of MR severity, could have
nfluenced management decisions. Although various causes
f organic MR were considered together (including pros-
hesis dysfunction), guidelines for intervention are the same
egardless of etiology.
onclusions
urgical intervention occurred in just over one-half of
atients with severe organic MR. One or more indication
or intervention was present in approximately three-fourths
f unoperated patients, suggesting poor adherence to guide-
ine recommendations. Despite a cited concern for high
perative risk, objectively assessed risks did not seem pro-
ibitive in most unoperated patients.
eprint requests and correspondence: Dr. David S. Bach, CVC
oom 2147, SPC 5853, 1500 East Medical Center Drive, Ann
rbor, Michigan 48109-5853. E-mail: dbach@umich.edu.
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